|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1100 15th Street, NW |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 3071-12
|
||||||||
|
6. House ID# 316200000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Allison C. Wiley, Political Action Coordinator |
Date | 04/21/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
H.R. 971 Community Pharmacy Fairness Act of 2007
H.R. 3700 Fair Medicaid Drug Payment Act of 2007
Public Law 110-28 and Public Law 110-90 Medicaid: Implementation of the Tamper-Resistant Prescription Pad Requirement
H.R. 3140 Saving Our Community Pharmacies Act of 2007
S. 1954 Pharmacy Improvement Act (PhAIM) of 2007
S. 1827 Pharmacist Access and Recognition in Medicare (PhARM) of 2007
S. 1951 Fair Medicaid Drug Payment Act of 2007
S. 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims
S. 2161 Community Pharmacy Fairness Act
Docket No. CMS-4133-P Medicare Program: Option for Prescription Drug Plans to Lower Their Premiums for Low-Income Subsidy Beneficiaries
S. 2464 Medicare Improvement Act of 2007
H.R. 4704 Medicare Improvement Act of 2007
H.R. 4992 Medicare Improvement Act of 2007
CMS 2009 Draft and Final 2009 Call Letter to Medicare Part D Plans
Docket No. CMS-0016-P Medicare Program: Proposed Standards for e-Prescribing under Medicare Part D
Docket No. CMS-2238-ICF Medicaid Program; Multiple Source Drug Definition
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochian |
|
|
|
Marcie |
Bough |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Docket No. FDA-2008-N-0120 Standards for Standardized Numerical Identifier, Validation, Track and Trace, and Authentication for Prescription Drugs
Docket No. FDA-2008-N-0121 Technologies for Prescription Drug Identification Validation, Track and Trace, or Authentication
Docket No. DEA-303P New Single Sheet Format for US Official Order Form for Schedule I & II Controlled Substances
Docket No. DEA-287F Issuance of Multiple Prescriptions of Schedule II Controlled Substances
Docket Number FDA-2008-D-0053 Good Reprint Practices for Distribution of Medical or Scientific References Publications or Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices
Docket No. FDA 2007N-0480 Maximizing the Public Health Benefit of Adverse Event Collection throughout a Product's Marketed Life Cycle
17. House(s) of Congress and Federal agencies Check if None
Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochian |
|
|
|
Marcie |
Bough |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S. Con. Res. 70 Concurrent Resolution on the Budget for Fiscal Year 2009
Public Law 110-181 National Defense Authorization Act of Fiscal Year 2008
President's FY 2009 Proposed Budget
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochian |
|
|
|
Marcie |
Bough |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Docket No. RIN 0919-AA01 Patient Safety and Quality Improvement Proposed Rule
S. 2456 Influenza Vaccine Security Act
S. 2465 Vaccines for Children Access Act of 2008
H.R. 4990 Vaccines for Children Access Act of 2008
H.R. 4702 Vaccines for Children Access Act of 2008
S. 2467 Vaccine Shortage Preparedness Act of 2008
H.R. 4703 Vaccine Shortage Preparedness Act of 2008
H.R. 4991 Vaccine Shortage Preparedness Act of 2008
S. 2476 Improved Vaccine Supply Act
H.R. 4251 Flu Vaccine Availability Act of 2008
H.R. 4331 Attacking Viral Influenza Across Nations Act of 2008
S. 2466 Vaccines for the Uninsured Adult Act of 2008
H.R. 4705 Vaccines for the Uninsured Adult Act of 2008
H.R. 4993 Vaccines for the Uninsured Adult Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochian |
|
|
|
Marcie |
Bough |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IND
16. Specific lobbying issues
S. 1200 Indian Health Care Improvement Act Amendments of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Lunner |
|
|
|
Hrant |
Jamgochian |
|
|
|
Marcie |
Bough |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |